Delivery Order SPE2DB20D2104-SPE2DB24FR66P
Award Date
12/15/23
Potential Completion Date
12/18/23
Potential Value
$4.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,353.18 contract is for the delivery of 4,563,971,686 units of NASCOBAL 500 MCG nasal sprays. The award has an ultimate completion date of March 15, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,562,677,219 units of NASCOBAL 500 MCG NASAL SPRAYS, with a ceiling value of $4,424.21. The contract has a performance period through November 2, 2023 and is a Firm Fixed Price contract type. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that serves as a critical supplier to...
This is a delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of NASCOBAL 500 MCG nasal sprays. The firm-fixed-price contract, valued at $3,544.49, has a completion date of July 24, 2024. It is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which...
This federal contract award, valued at $1,329.27, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of NASCOBAL 500 MCG NASAL SPRAYS, a pharmaceutical product, to the DLA. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical. This single-award IDC serves as the primary vehicle for...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical company AmerisourceBergen Corporation. The $11,679.27 contract is for the supply of NASCOBAL 500 MCG nasal sprays to support military treatment programs and facilities. This delivery order is part of a larger indefinite delivery contract (IDC) between DLA and AmerisourceBergen Drug Corp, valued at up to $999,999,999.00 through December...
This federal contract award is for the delivery of NASCOBAL 500 MCG NASAL SPRAYS to the Defense Logistics Agency (DLA). The $1,469.21 firm fixed price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of April 19, 2024 and was awarded on April 18, 2024. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,534.36 firm fixed-price delivery order is for the supply of NASCOBAL 500 MCG nasal sprays, with a completion date of September 15, 2023. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of NASCOBAL 500 MCG nasal sprays. The contract has a ceiling value of $1,809.79 and is a firm-fixed-price delivery order with a completion date of January 31, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,699.92 Firm Fixed Price delivery order is for 4,560 units of NASCOBAL 500 MCG nasal sprays, with a completion date of March 22, 2023. The award is not designated under any set-aside program, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award is for the delivery of NASCOBAL 500 MCG NASAL SPRAYS to the Defense Logistics Agency (DLA). The $10,356.87 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has an ultimate completion date of July 21, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that serves as a critical supplier to various government agencies, particularly the Department of Defense (DoD) and Department of...